First Horizon Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

First Horizon Advisors’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-25	Closed	-$347	–	2374
2023 Q4	$347	Sell	25 -95	-79%	-$1.27K	﹤0.01%	2318
2023 Q3	$1.6K	Buy	+120	New	+$1.62K	﹤0.01%	2047
2023 Q2	–	Sell	-335	Closed	-$3.81K	–	2514
2023 Q1	$3.81K	Buy	+335	New	+$3.62K	﹤0.01%	1890
2017 Q1	–	Sell	-60	Closed	–	–	1563
2016 Q4	$0	Hold	60	–	–	﹤0.01%	1454
2016 Q3	$0	Buy	+60	New	+$573	﹤0.01%	1489
2016 Q1	–	Sell	-40	Closed	–	–	1384
2015 Q4	$0	Hold	40	–	–	﹤0.01%	1355
2015 Q3	$0	Hold	40	–	–	﹤0.01%	1438
2015 Q2	$0	Buy	40 +25	+167%	+$276	﹤0.01%	1482
2015 Q1	$0	Sell	15 -70	-82%	-$743	﹤0.01%	1548
2014 Q4	$0	Buy	+85	New	+$895	﹤0.01%	1545
2013 Q4	–	Sell	-200	Closed	-$2K	–	1388
2013 Q3	$2K	Buy	200 +15	+8%	+$109	﹤0.01%	1081
2013 Q2	$1K	Buy	+185	New	+$1.35K	﹤0.01%	901

Other funds holding RDY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

First Horizon Advisors's RDY Position: Q1 2024 in Review

First Horizon Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q1 2024, closing a stake of 25 shares — an estimated $347 sold.

First Horizon Advisors first reported a position in RDY in Q2 2013 and held it in 12 quarters. The position peaked at $3.81K in Q1 2023. 231 funds tracked by Wall St. Rank hold RDY as of Q1 2024.

First Horizon Advisors reported no remaining Dr. Reddy's Laboratories position as of Q1 2024 after selling out during the quarter.
First Horizon Advisors sold 25 Dr. Reddy's Laboratories shares in Q1 2024, an estimated $347.
First Horizon Advisors first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 12 quarters.
First Horizon Advisors's Dr. Reddy's Laboratories position peaked at $3.81K in Q1 2023.
231 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2024.

Based on First Horizon Advisors's 13F filing for Q1 2024, filed 26 Apr 2024.